Search

Previous Meetings

All of the meetings on this page took place in 2024. The most recent meetings are listed first. To view meetings from previous years, use the navigation menu.

Read more

Red Cells and Iron

This SWG covers the clinical areas of inherited and acquired disorders of the erythrocyte and iron metabolism.

Read more

Chairs and Members

ChairPaolo Gresele, Department of Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia (Italy)

Vice-ChairTo be announced.

Read more

European Research Initiative on CLL (ERIC)

ERIC is devoted to improving the outcome of patients with Chronic Lymphocytic Leukemia (CLL) and related diseases. The objectives of ERIC are to promote:

Research in all aspects of chronic lymphocytic leukemia and related diseases.

Read more

Chairs and Members

Chair (2017-ongoing)Oliver A. Cornely—University Hospital Cologne, Cologne (Germany)

Co-chair (2023-ongoing)Livio Pagano—Fondazione Policlinico A.

Read more

Infections in Hematology

A recent publication in Clinical Infectious Diseases "Global differences in the management of Staphylococcus aureus bacteremia" revealed substantial variation in treatment practices across the world.

Read more

Chairs and Members

Chair (2022–2024 term)Edward Laane

Co-chairs (2022–2024 term)
Esther Natalie Oliva
Sam Salek
Secretary (2022–2024 term)Tatyana Ionova

SWG Executive Board members (2022–2024 term)
Tatiana Ionova, Сhair of Department, St. Petersburg State University Hospital, St.

Read more

Chairs and Members

ChairJane Apperley

Co-chairAndreas Hochhaus

Executive Board members (2021–2027 term)
Prof Nicholas CP Cross, University of Southampton (UK)
Prof Oliver Hantschel, University of Marburg (Germany)
Dr Delphine Rea, University of Paris (France)
Dr Katerina Machova Polakova, Institute of Hematology and Blood Transfusion, Prague; Charles University (Czech Republic)
Prof…

Read more

Publications

Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors
Atallah E, Mauro MJ, Hochhaus A, Boquimpani C, Minami Y, Maheshwari VK, Saini L, Corbin R, Réa D.

Read more

Welcome to the EHA2025 Sponsor Program

On this page, you can browse and/or download the interactive EHA2025 Sponsor Program. If the EHA2025 Sponsor Program does not display correctly, please click here or download the file.  

Read more